(PHEQ) Morgan Stanley Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US61774R8741

PHEQ: Equity, Stocks, Hedging, US Large-Caps, Growth

The Morgan Stanley ETF Trust (PHEQ) is an actively managed exchange-traded fund that focuses on capital appreciation by investing in a subset of large-cap U.S. equities, specifically constituents of the Solactive GBS U.S. 500 index at the time of purchase. This strategy implies a selective approach to capturing growth opportunities within the large-cap segment, potentially offering a more nuanced exposure compared to broader market indices.

Analyzing the funds characteristics, its categorized under Equity Hedged ETFs, suggesting its investment strategy may incorporate hedging techniques to mitigate potential downsides or capitalize on market inefficiencies. The funds underlying assets are equity securities of large-cap U.S. companies, which typically possess the characteristics of liquidity, stability, and market leadership, potentially offering a balance between growth and risk management.

Examining the technical indicators, the funds price action relative to its moving averages (SMA20: 28.66, SMA50: 28.47, SMA200: 28.84) and the current price (29.78) indicates a bullish short-term trend, as it is trading above its short, medium, and long-term moving averages. The Average True Range (ATR) of 0.42 or 1.42% suggests relatively contained volatility, which could be appealing to investors seeking exposure with managed risk. The 52-week high and low range (30.44 to 26.62) further contextualizes the current price within its recent trading history, showing a recovery or growth from its lows.

From a fundamental perspective, the Assets Under Management (AUM) of $92.93M USD indicate a relatively modest size, which could be a double-edged sword; it might limit the funds ability to diversify extensively but also suggests potential for agility in its investment strategy. The Equity Hedged category implies a strategic approach to risk management, potentially making it an attractive option for investors looking to balance their portfolios against market downturns or volatility.

Forecasting the funds trajectory involves synthesizing technical and fundamental insights. Given its current price above key moving averages and relatively low volatility, the technical outlook is cautiously optimistic. If the AUM continues to grow, it could enhance the funds stability and attract more investors, potentially driving the price upwards. Conversely, failure to attract new capital or significant outflows could pressure the price. Assuming the Solactive GBS U.S. 500 index continues to perform well and the funds hedging strategy effectively manages downside risk, PHEQ could see further capital appreciation. A potential target could be the 52-week high of 30.44, representing a 2.2% increase from the current price, though this would depend on broader market conditions and the funds ability to maintain its strategic edge.

Additional Sources for PHEQ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

PHEQ ETF Overview

Market Cap in USD 94m
Category Equity Hedged
TER 0.29%
IPO / Inception 2023-10-16

PHEQ ETF Ratings

Growth Rating 52.5
Fundamental -
Dividend Rating 16.7
Rel. Strength -0.68
Analysts -
Fair Price Momentum 28.90 USD
Fair Price DCF -

PHEQ Dividends

Dividend Yield 12m 1.45%
Yield on Cost 5y 1.78%
Annual Growth 5y -4.21%
Payout Consistency 95.7%
Payout Ratio %

PHEQ Growth Ratios

Growth Correlation 3m 76.2%
Growth Correlation 12m 61.1%
Growth Correlation 5y 90.9%
CAGR 5y 14.84%
CAGR/Max DD 5y 1.18
Sharpe Ratio 12m 1.47
Alpha 2.05
Beta 0.541
Volatility 5.39%
Current Volume 5.1k
Average Volume 20d 3.9k
What is the price of PHEQ shares?
As of June 19, 2025, the stock is trading at USD 30.07 with a total of 5,146 shares traded.
Over the past week, the price has changed by -0.36%, over one month by +0.98%, over three months by +5.10% and over the past year by +9.56%.
Is Morgan Stanley Trust a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Morgan Stanley Trust (NYSE ARCA:PHEQ) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.54 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PHEQ is around 28.90 USD . This means that PHEQ is currently overvalued and has a potential downside of -3.89%.
Is PHEQ a buy, sell or hold?
Morgan Stanley Trust has no consensus analysts rating.
What are the forecasts for PHEQ share price target?
According to our own proprietary Forecast Model, PHEQ Morgan Stanley Trust will be worth about 31.9 in June 2026. The stock is currently trading at 30.07. This means that the stock has a potential upside of +6.09%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.9 6.1%